Real-world results confirm the benefits of dosing ZOMETA® every 3 to 4 weeks in patients like Anthony15
- Using alternative dosing schedules significantly compromises the benefits of ZOMETA15
Rate of SREs by dosing regimen15*
*There are limitations to the study because the results are from a retrospective claims
database analysis.
- Treatment with ZOMETA 4 mg every 3 to 4 weeks significantly reduced the rate of skeletal morbidity (measured as number of events per month) vs no treatment15
- No other dosing schedule is proven to protect patients from SREs2,12-14
ZOMETA is proven in clinical trials to delay and reduce SREs in lung cancer and other solid tumors through 21 months2
Achieve maximum potential benefit—treat with ZOMETA 4 mg every 3 to 4 weeks
